Newsroom - BIOTRONIK

Press releases

BIOTRONIK Announces First Enrollments to BIOVITESSE Trial

, Medical Technology

BIOTRONIK has announced the start of enrollment of a coronary stent trial aiming at assessing the safety and clinical performance of a new coronary...

BIOTRONIK CLS Technology Shown to Reduce Fainting in Syncope Patients by Seven-Fold

, Medical Technology

BIOTRONIK’s exclusive rate responsive technology, Closed Loop Stimulation (CLS) has shown to reduce fainting in pacemaker patients with vasovagal...

CIRSE 2017: BIOTRONIK Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy

, Medical Technology

Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce restenosis rates, according...

BIOFLOW-V Studie hat gezeigt: Der ultradünne Medikament-freisetzende "Orsiro" Stent ist effektiver und sicherer als der "Xience" Stent

, Medical Technology

Auf dem diesjährigen Kongress der Europäischen Gesellschaft für Kardiologie (ESC)  wurden die BIOFLOW-V Studienergebnisse im Rahmen einer „Hotline...

2017 ESC (欧州心臓病学会):BIOFLOW-V 試験において バイオトロニック社製オシロ薬剤溶出型ステントがザイエンスよりも優れた成績を示す

, Medical Technology

バイオトロニック社は、オシロDES(Or­siro DES: オシロ薬剤溶出型ステント)とザイエンスD­ESを比較したBIOFLOW-V無作為化試験の主要評価項目である12か­月までの標的病変不全(TLF)の結果を発­表しました。 2017 ESC(欧州心臓病学会)とThe Lancetで発表された結果は、12か月­までのTLF発生率(オシロDES...

European Heart Rhythm Association and BIOTRONIK Mark Ten Years of Collaboration with EHRA White Book 2017 Analysis

, Medical Technology

The European Heart Rhythm Association (EHRA) released the analytical supplement to the 10th EHRA White Book during the ESC Congress 2017 in Barcelona. Supporte­d...

CASTLE-AF Study Results Indicate Catheter Ablation of Atrial Fibrillation as First-Line Treatment for Heart Failure Patients

, Medical Technology

Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause mortality and hospitalization for worsening...

CASTLE-AF Studie könnte Katheterablation als Standardverfahren für Herzinsuffizienzpatienten mit Vorhofflimmern etablieren

, Medical Technology

Die Auswertung der CASTLE-AF (Catheter Ablation versus Standard Conventional Treatment in Patients with Left Ventricular Dysfunction and Atrial...

Late-Breaking BIOTRONIK Study Results to Be Presented at ESC Congress 2017

, Medical Technology

Cardiology experts will present conclusive results from various BIOTRONIK studies at the European Society of Cardiology’s ESC Congress 2017. The...

BIOTRONIK's Newest CRT-D Device with MultiPole Pacing Now Available in Japan

, Medical Technology

BIOTRONIK’s highest performing cardiac resynchronization therapy defibrillator (CRT-D) is now available in Japan. With several key technologies,...

BIOTRONIK's New Quadripolar CRT-P with More Pacing Options Now Available in Japan

, Medical Technology

BIOTRONIK has announced the launch of its Evity cardiac resynchronization therapy pacemaker (CRT-P) in the Japanese market. It is the company’s...

EPIC Alliance Discusses MR Conditional Devices and Best Practices at Europace-Cardiostim 2017

, Medical Technology

Physicians exchanged ideas on MR conditional devices in the scientific symposium “Clinical Decision Making in Electrophysiology/ Arrhythmias”...

Europace-Cardiostim 2017: Challenges and New Opportunities in Heart Failure Management

, Medical Technology

BIOTRONIK Studies Highlight Pertinent Questions: Can We Avoid ICD Therapy? Do CRT Patients Benefit from Rate-Adaptive Pacing? What is the Role...

Europace-Cardiostim 2017: Herausforderungen und Chancen für das Herzinsuffizienzmanagement

, Medical Technology

BIOTRONIK Studien adressieren wichtige Fragen: Bei welchen CRT-Patienten ist die Defibrillatortherapi­e wirklich erforderlich? Profitieren CRT-Patienten...

BIOTRONIK Receives CE Mark for 3 Tesla Full-Body MRIs with Newest Pacemakers

, Medical Technology

BIOTRONIK received CE approval for 3 tesla (T) full-body scans (FBS) with its latest range of MR conditional pacemaker systems. Patients implanted...

Media

Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
BIOTRONIK
Woermannkehre 1
D - 12359 Berlin




Contact

Frau Manuela Schildwächter


Communications & PR Manager
BIOTRONIK SE & Co. KG

Phone +49 30 689051414

all contacts

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.